Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2012 Sep;64(9):1373–1381. doi: 10.1002/acr.21704

Table 2.

Clinical and demographic characteristics of pregnantmothers.

Group 1 (N=50) Group 2 (N=32) Group 3 (N=33) P-value 1 vs. 2 P-value 1 vs. 3
Clinical Diagnosis 0.5 0.2
 Asymptomatic 15 (30%) 7 (22%) 5 (15%)
 UAS 11 (22%) 8 (25%) 6 (18%)
 SS 13 (26%) 12 (38%) 8 (24%)
 SLE/SS 5 (10%) 3 (9%) 5 (15%)
 SLE 4 (8%) 2 (6%) 7 (22%)
 Other/NA 2 (4%) 0 (0%) 2 (6%)
Race/ethnicity 1.0 0.5
 White 41 (82%) 25 (79%) 11 (33%)
 Black 2 (4%) 2 (6%) 0 (0%)
 Hispanic 2 (4%) 0 (0%) 3 (9%)
 Asian 4 (8%) 3 (9%) 1 (3%)
 Other/NA 1 (2%) 2 (6%) 18 (55%)
Antibody Status
 Anti-Ro52 50 (100%) 32 (100%) 29 (88%) 1.0 0.022
 Anti-p200 44 (88%) 31 (97%) 22 (67%) 0.2 0.026
 Anti-Ro60 50 (100%) 32 (100%) 33 (100%) 1.0 1.0
 Anti-La 26 (52%) 19 (59%) 17 (52%) 0.6 1.0

Group 1: cardiac NL pregnancy, 3rd degree block (n=42), 2nd degree (n=1), 1st degree (n=3), cardiomyopathy (n=5), sinus bradycardia (n=2). Twins discordant for cardiac NL (n=4).

Group 2: unaffectedpregnancy, mother had aprevious child with cardiac NL. Healthy (n=29), cutaneous NL (n=4).

Group 3: unaffectedpregnancy, mother has only unaffected children, cutaneous NL (n=3), hepatic/hematological complications (n=1).

UAS= undifferentiated autoimmune syndrome, SS= Sjögren’s syndrome, SLE= systemic lupus erythematosus, NA= not available

HHS Vulnerability Disclosure